Your browser doesn't support javascript.
loading
Use of period analysis to timely assess 5-year relative survival for breast cancer patients from Taizhou, Eastern China.
Li, Runhua; Zheng, Yabing; Huang, Jiajia; Lei, Huijun; Xu, Mingzhi; Wang, Liangyou; Zhang, Luyao; Cheng, Yongran; Jiang, Xiyi; Tang, Huijuan; Shi, Zheng; Chen, Gang; Zhou, Huijuan; Dai, Zhijun; Lu, Dalin; Chen, Tianhui.
Afiliação
  • Li R; Department of Cancer Prevention/Zhejiang Cancer Institute, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Zheng Y; Department of Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Huang J; Department of Epidemiology, School of Medicine, Jinan University, Guangzhou, China.
  • Lei H; Department of Cancer Prevention/Zhejiang Cancer Institute, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Xu M; Department of General Medicine, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Wang L; Department of Non-communicable Chronic Disease Control and Prevention, Taizhou Center for Disease Control and Prevention, Taizhou, China.
  • Zhang L; Department of Cancer Epidemiology and Prevention, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Cheng Y; School of Public Health, Hangzhou Medical College, Hangzhou, China.
  • Jiang X; School of Public Health, Hangzhou Medical College, Hangzhou, China.
  • Tang H; School of Public Health, Hangzhou Medical College, Hangzhou, China.
  • Shi Z; Department of Cancer Prevention/Zhejiang Cancer Institute, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Chen G; Department of Cancer Prevention/Zhejiang Cancer Institute, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Zhou H; Department of Cancer Prevention/Zhejiang Cancer Institute, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Dai Z; Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Lu D; Department of Epidemiology, School of Medicine, Jinan University, Guangzhou, China.
  • Chen T; Department of Cancer Prevention/Zhejiang Cancer Institute, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Front Oncol ; 12: 998641, 2022.
Article em En | MEDLINE | ID: mdl-36578940

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article